Abstract
The purpose of this study was to obtain genetic counselors’ perspectives about the identification of appropriate patients and barriers to referral of high-risk patients for cancer genetic counseling services. Genetic service providers from eight integrated health systems were surveyed. Data analysis included descriptive statistics. Twenty-eight of 40 potential participants responded (70%). Referrals for familial cancer risk assessment overwhelmingly came from providers (89%); only 10% were self-referrals. Use of guidelines to assist providers with referral was reported by 46% of the respondents. Genetic service providers perceived patient barriers to seeking genetic counseling after referral included: risk evaluation viewed as a non-priority (72%), concerns about impact on insurability (52%), distance to appointments (48%), lack of insurance (44%), lack of patient/provider knowledge about the value of genetic counseling (36%), discouragement by family members (28%), and fear (20%). The best approaches suggested by respondents to increase appropriate referrals were attending meetings and giving presentations to oncologists, surgeons, primary care and gynecologists. The genetic service providers reported several barriers to the referral and use of genetic counseling. This finding is consistent with current literature from the providers’ perspective. Our survey adds the genetic service providers’ perspective and identifies areas of opportunity for further research and intervention as few of the perceived barriers are being addressed through current educational efforts.
Similar content being viewed by others
References
(2009a). Colon Cancer. NCNN clinical practice guidelines in oncology (NCCN GuidelinesTM) Retrieved March 3, 2009, from www.nccn.org.
(2009b). Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine, 11, 35–41
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., et al. (2009). American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. Journal of Clinical Oncology, 27, 2091–2096.
American Cancer Society. (2006). Minnesota cancer facts and figures 2006. Mendota Heights, American Cancer Society, Midwest Division.
American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21, 2397–2406.
Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev, 9, 1251–1254.
Berg, A. O., Baird, M. A., Botkin, J. R., Driscoll, D. A., Fishman, P. A., Guarino, P. D., et al. (2009). National institutes of health state-of-the-science conference statement: family history and improving health. Annals of Internal Medicine, 151, 872–877.
Brierley, K. L., Campfield, D., Dohany, L., Donenberg, T., Ducaine, W., Matloff, E. T., et al. (2010). Errors in delivery of cancer genetics services: Implications for pactice. Connecticut Medicine, 74, 413–423.
Brooks, L., Lennard, F., Shenton, A., Lalloo, F., Ambus, I., Ardern-Jones, A., et al. (2004). BRCA1/2 predictive testing: a study of uptake in two centres. European Journal of Human Genetics, 12, 654–662.
Calzone, K. A., Prindiville, S. A., Jourkiv, O., Jenkins, J., DeCarvalho, M., Wallerstedt, D. B., et al. (2005). Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. Journal of Clinical Oncology, 23, 3455–3464.
Facio, F. M., Feero, W. G., Linn, A., Oden, N., Manickam, K., & Biesecker, L. G. (2010). Validation of my family health portrait for six common heritable conditions. Genetics in Medicine, 12, 370–375.
Flynn, B. S., Wood, M. E., Ashikaga, T., Stockdale, A., Dana, G. S., & Naud, S. (2010). Primary care physicians’ use of family history for cancer risk assessment. BMC Family Practice, 11, 45.
Frezzo, T. M., Rubinstein, W. S., Dunham, D., & Ormond, K. E. (2003). The genetic family history as a risk assessment tool in internal medicine. Genetics in Medicine, 5, 84–91.
Geer, K. P., Ropka, M. E., Cohn, W. F., Jones, S. M., & Miesfeldt, S. (2001). Factors influencing patients’ decisions to decline cancer genetic counseling services. Journal of Genetic Counseling, 10, 25–40.
Guerra, C. E., Sherman, M., & Armstrong, K. (2009). Diffusion of breast cancer risk assessment in primary care. Journal of the American Board of Family Medicine, 22, 272–279.
Guttmacher, A. E., Collins, F. S., & Carmona, R. H. (2004). The family history—more important than ever. The New England Journal of Medicine, 351, 2333–2336.
Johnson, B. M. (2007). Personal communication—unpublished data based on a health plan examination of family history data
Julian-Reynier, C., Sobol, H., Sevilla, C., Nogues, C., & Bourret, P. (2000). Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psychooncology, 9, 504–510.
Khoury, M. J. (2003). Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genetics in Medicine, 5, 261–268.
Khoury, M. J., Gwinn, M., Yoon, P. W., Dowling, N., Moore, C. A., & Bradley, L. (2007). The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genetics in Medicine, 9, 665–674.
Khoury, M. J., Feero, W. G., & Valdez, R. (2010). Family history and personal genomics as tools for improving health in an era of evidence-based medicine. American Journal of Preventive Medicine, 39, 184–188.
Lerman, C., Biesecker, B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., et al. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute, 89, 148–157.
Matloff, E., & Caplan, A. (2008). Direct to confusion: lessons learned from marketing BRCA testing. The American Journal of Bioethics, 8, 5–8.
Meiser, B., Butow, P. N., Barratt, A. L., Schnieden, V., Gattas, M., Kirk, J., et al. (2001). Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Education and Counseling, 44, 215–225.
Morgan, D. L. (1988). Focus groups and qualitative research. Newberry Park: Sage.
Mouchawar, J., Klein, C. E., & Mullineaux, L. (2001). Colorado family physicians’ knowledge of hereditary breast cancer and related practice. Journal of Cancer Education, 16, 33–37.
Murff, H. J., Spigel, D. R., & Syngal, S. (2004). Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. Jama, 292, 1480–1489.
Office of the Surgeon General. (2009a). Surgeon General’s family health history initiative. Retrieved November 19, 2009, from http://www.hhs.gov/familyhistory/.
Office of the Surgeon General. (2009b). Surgeon General’s new family health history tool is released, ready for “21st century medicine”. Retrieved September 10, 2009, from http://www.hhs.gov/news/press/2009pres/01/20090113a.html.
O’Neill, S. M., Peters, J. A., Vogel, V. G., Feingold, E., & Rubinstein, W. S. (2006). Referral to cancer genetic counseling: are there stages of readiness? American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 142C, 221–231.
Oregon Evidence-based Practice Center and U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Evidence Synthesis. Number 37. Retrieved August 11, 2009, from http://www.ahrq.gov/Clinic/uspstf/uspsbrgen.htm.
Pieterse, A. H., van Dulmen, A. M., Ausems, M. G., Beemer, F. A., & Bensing, J. M. (2005). Communication in cancer genetic counselling: does it reflect counselees’ previsit needs and preferences? British Journal of Cancer, 92, 1671–1678.
Qureshi, N., Carroll, J. C., Wilson, B., Santaguida, P., Allanson, J., Brouwers, M., et al. (2009). The current state of cancer family history collection tools in primary care: a systematic review. Genetics in Medicine, 11, 495–506.
Rahm, A. K., Sukhanova, A., Ellis, J., & Mouchawar, J. (2007). Increasing utilization of cancer genetic counseling services using a patient navigator model. Journal of Genetic Counseling, 16, 171–177.
Ramsey, S. D., Burke, W., Pinsky, L., Clarke, L., Newcomb, P., & Khoury, M. J. (2005). Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev, 14, 2494–2500.
Ramsey, S. D., Yoon, P., Moonesinghe, R., & Khoury, M. J. (2006). Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genetics in Medicine, 8, 571–575.
Reid, G. T., Walter, F. M., Brisbane, J. M., & Emery, J. D. (2009). Family history questionnaires designed for clinical use: a systematic review. Public Health Genomics, 12, 73–83.
SAS Institute. (2006). Base SAS 9.1.3 procedures guide. Cary: SAS Institute, Inc.
Scheuner, M. T., de Vries, H., Kim, B., Meili, R. C., Olmstead, S. H., & Teleki, S. (2009). Are electronic health records ready for genomic medicine? Genetics in Medicine, 11, 510–517.
Schlich-Bakker, K. J., ten Kroode, H. F., Warlam-Rodenhuis, C. C., van den Bout, J., & Ausems, M. G. (2007). Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer. Genetics in Medicine, 9, 766–777.
Silverman, D. (1993). Interpreting qualitative data: Methods for analysing talk, text and interaction. London: Sage.
Simon, C., Acheson, L., Burant, C., Gerson, N., Schramm, S., Lewis, S., et al. (2008). Patient interest in recording family histories of cancer via the Internet. Genetics in Medicine, 10, 895–902.
Smith, R. A., Cokkinides, V., & Eyre, H. J. (2007). Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA: A Cancer Journal for Clinicians, 57, 90–104.
Sussner, K. M., Jandorf, L., Thompson, H. S., & Valdimarsdottir, H. B. (2010). Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City. Journal of Genetic Counseling, 19, 255–268.
Suther, S., & Goodson, P. (2003). Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genetics in Medicine, 5, 70–76.
Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S. C., et al. (2004). Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 13, 83–114.
Valdez, R., Yoon, P. W., Qureshi, N., Green, R. F., & Khoury, M. J. (2010). Family history in public health practice: a genomic tool for disease prevention and health promotion. Annual Review of Public Health, 31, 69–87. 61 p following 87.
Volk, L. A., Staroselsky, M., Newmark, L. P., Pham, H., Tumolo, A., Williams, D. H., et al. (2007). Do physicians take action on high risk family history information provided by patients outside of a clinic visit? Studies in Health Technology and Informatics, 129(Pt 1), 13–17.
Wagner, E. H., Greene, S. M., Hart, G., Field, T. S., Fletcher, S., Geiger, A. M., et al. (2005). Building a research consortium of large health systems: the Cancer Research Network. Journal of the National Cancer Institute Monographs, 3–11
Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C. N., Davis, W., Srinath, K. P., et al. (2003). Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev, 12, 295–303.
Wideroff, L., Vadaparampil, S. T., Greene, M. H., Taplin, S., Olson, L., & Freedman, A. N. (2005). Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics, 42, 749–755.
Wilson, B. J., Qureshi, N., Santaguida, P., Little, J., Carroll, J. C., Allanson, J., et al. (2009). Systematic review: family history in risk assessment for common diseases. Annals of Internal Medicine, 151, 878–885.
Wood, M. E., Stockdale, A., & Flynn, B. S. (2008). Interviews with primary care physicians regarding taking and interpreting the cancer family history. Family Practice, 25, 334–340.
Acknowledgements
This study was funded by the National Cancer Institute, contract 5U19 CA079689, “Increasing the Effectiveness of Cancer Control Interventions” (Edward H. Wagner, MD, MPH, Principal Investigator), which provides financial support for the HMO Cancer Research Network (CRN). We want to acknowledge the members of the CRN Family History Scientific Interest Group who contributed to the conceptual design of this project and/or provided input on this manuscript, particularly Andrea F. Patenaude, PhD from the Dana Farber Cancer Institute (Boston, MA). We also want to thank the genetics professionals who participated in the survey. The corresponding author may be contacted to request a copy of the full survey.
Confict of Interest
No disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rolnick, S.J., Rahm, A.K., Jackson, J.M. et al. Barriers in Identification and Referral to Genetic Counseling for Familial Cancer Risk: The Perspective of Genetic Service Providers. J Genet Counsel 20, 314–322 (2011). https://doi.org/10.1007/s10897-011-9351-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-011-9351-3